Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Jean Pan"'
Autor:
Austin Kulasekararaj, Francesco Lanza, Alexandros Arvanitakis, Saskia M.C. Langemeijer, Satheesh Chonat, Vincent Chow, Jean Pan, Yaneth Saportas, Vladimir Hanes, Haby Henary
Publikováno v:
Blood. 140:8660-8662
Publikováno v:
Real-Time Image Processing and Deep Learning 2022.
Publikováno v:
European Journal of Haematology. 105:66-74
Objectives ABP 959 is a proposed biosimilar to eculizumab, a monoclonal antibody targeting the human C5 complement protein. The objective of this randomized, double-blind, three-arm, study was to demonstrate pharmacokinetic (PK) and pharmacodynamic (
Publikováno v:
2021 IEEE/AIAA 40th Digital Avionics Systems Conference (DASC).
A data mule is a vehicle used to physically transfer data between locations, providing asynchronous connectivity without the expense of establishing traditional networking solutions (e.g., cellular, mesh, wired broadband, etc.). In remote areas, fiel
Autor:
Lucas A. Overbey, Todd van Epps, Jean Pan, Jamie R. Lyle, Alan Jaegar, Branson Holt, Ryan Jaeger, Martin Ruane
Publikováno v:
Geospatial Informatics XI.
Deep convolutional neural networks (CNNs) have proven to be successful for learning task-specific features that achieve state-of-the-art performance on many computer vision tasks. For object detection applications, the introduction of region-based CN
Publikováno v:
European Journal of Haematology
Objectives ABP 959 is a proposed biosimilar to eculizumab, a monoclonal antibody targeting the human C5 complement protein. The objective of this randomized, double‐blind, three‐arm, study was to demonstrate pharmacokinetic (PK) and pharmacodynam
Publikováno v:
Clinical pharmacology in drug developmentReferences. 9(8)
ABP 798 is a proposed biosimilar to rituximab reference product (RP), an anti-CD20 monoclonal antibody. Pharmacokinetics (PK), pharmacodynamics (PD), and safety results from the comparative clinical study that evaluated the PK, PD, safety, efficacy,
Autor:
Ryan Jaegar, Lucas A. Overbey, Todd van Epps, Jamie R. Lyle, Alan Jaegar, Martin Ruane, Georgianna Campbell, Jean Pan
Publikováno v:
Infrared Imaging Systems: Design, Analysis, Modeling, and Testing XXX.
Publikováno v:
Biometrics
In this paper, we propose a Bayesian design framework for a biosimilars clinical program that entails conducting concurrent trials in multiple therapeutic indications to establish equivalent efficacy for a proposed biologic compared to a reference bi
Publikováno v:
Blood. 134:3520-3520
Background: ABP 959 is being developed as a biosimilar to eculizumab, a recombinant humanized IgG2/4 chimeric monoclonal antibody that binds to the human C5 complement protein (C5), thereby inhibiting the complement cascade. Eculizumab is indicated f